Yahoo India Web Search

Search results

    • FDA clears Artelo’s FABP5 inhibitor trial

      FDA clears Artelo’s FABP5 inhibitor trial

      Clinical Trials Arena· 2 hours ago

      Artelo is developing ART26.12 as a non-opioid approach for managing painful neuropathies. The drug targets FABP5, an intracellular protein involved in...